Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2006, p. 1248-1257, Vol. 72, No. 2
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.2.1248-1257.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Lehrstuhl für Angewandte Mikrobiologie, Universität des Saarlandes, 66123 Saarbrücken, Germany,1 Danisco Innovation, Danisco A/S, Langebrogade 1, P.O. Box 17, Copenhagen, Denmark2
Received 8 August 2005/ Accepted 11 November 2005
|
|
|---|
|
|
|---|
-(1,4)-glucan lyase (EC 4.2.2.13; GLase) (50), which catalyzes the release of AF from the nonreducing end of
-(1,4)-glucans (26). The enhanced availability of AF from renewable resources promoted research to utilize AF as a starting material for various syntheses (4, 15, 31, 48). In biological systems AF was first detected in fungi, where it originated from glycogen through degradation by GLase (6, 13). In ascomycetes, discomycetes, and red algae AF is the metabolic precursor to antimicrobial secondary products such as ascopyrones, microthecin, and epipentenomycin I (7, 13), for which the complete pathway was elucidated only recently in the fungus Anthracobia melaloma (51). Although occurring in very small amounts, AF was found in bacteria (37), algae (9), higher plants (22), animal tissues (19), and human cell lines (46), suggesting the ubiquitous distribution of AF in living organisms. In Escherichia coli, as well as in plant and mammalian tissues AF is an intermediate in the formation of 1,5-anhydro-D-glucitol (AG) catalyzed by a specific NADPH-dependent anhydrofructose reductase (EC 1.1.1.263) (19, 22, 37). The widespread occurrence of the lyticnext to the established hydrolyticand phosphorolytic glycogen degradation raised questions as to its metabolic role (19). In mammals, AF or AG, respectively, seems to stimulate insulin secretion (1, 46), and in humans differences in the AG serum concentrations between healthy and diabetic individuals were observed, having rendered AG a glycemic marker in diabetic control (10). Based on observations in various organisms that only a small fraction of glycogen is degraded to AF, it was assumed that AF and/or AG might play regulatory roles in the glycogen metabolism (19, 37). In E. coli C600 physiological evidence pointed to the possibility that AG promotes glycogenolysis, presumably by intervening with a signal pathway (36). Here, we report on a microbial screening on AF yielding the bacterial strain Sinorhizobium morelense S-30.7.5, and we describe a new pathway by which AF is converted into the metabolizable sugar D-mannose. The first enzyme of this pathway was characterized as a new AFR with a unique substrate specificity and stereospecificity. We could assign AFR to the GFO/IDH/MocA family with an EC number of 1.1.1.- and demonstrated its general occurrence among the Rhizobiaceae. The AFR gene cloned from S. morelense S-30.7.5 was identified as the chromosomal locus SMc04400 in S. meliloti 1021, which now has a concrete function. Finally, we emphasize the biotechnological potential of AFR for use in the enzymatic analysis of AF and as a new biocatalyst for the efficient synthesis of rare sugars.
|
|
|---|
Strains, growth conditions, and screening.
S. morelense S-30.7.5, an isolate of this laboratory, was deposited as a patent strain (DSM 15760) at the German Culture Collection (Deutsche Sammlung von Mikroorganismen und Zellkulturen [DSMZ], Braunschweig, Germany). The reference strains Sinorhizobium meliloti DSM 1981, Ensifer fredii DSM 5851, Ensifer arboris DSM 13375, Rhizobium leguminosarum DSM 30132, Rhizobium trifolii DSM 30141, Mesorhizobium lotiDSM 2626, Mesorhizobium tianshanense DSM 11417, Bradyrhizobium japonicum DSM 30131, and Azorhizobium caulinodans DSM 5975 were obtained from DSMZ. The bacterial strains were grown at 28°C in Erlenmeyer flasks with shaking (142 rpm) in a mineral medium (pH 6.8) (29), supplemented with AF, D-mannose, or D-glucose (each 10 mM). Solid media contained 1.5% (wt/vol) of agar. For screening of microorganisms, soil samples were collected from the botanic garden of the Saarland University (Saarbrücken, Germany), suspended in 0.9% (wt/vol) saline solution and, after appropriate dilution, spread onto agar plates containing the medium described above with 1.8 mM AF. After 3 to 15 days of aerobic incubation at 28°C, the colonies formed were purified by standard techniques and grown in 5 ml of mineral medium. Larger batches were grown in 1.5-liter mineral medium at 28°C using a 2-liter bioreactor (Biolab CP; Braun, Melsungen, Germany) with pH regulation, aeration (4-liter air/min) and agitation (500 rpm). Escherichia coli TOP10 (Invitrogen, Karlsruhe, Germany) and E. coli BL21(DE3) (Novagen, Madison, Wis.) were recipients of cloning vectors and expression plasmids, respectively. They were grown on Luria-Bertani (LB) medium under appropriate selective conditions (33). Recombinant E. coli BL21(DE3) cells harboring plasmid pA6Ch1 and pA6Ch1HIS (see below), respectively, were grown in the bioreactor on LB medium at 37°C supplemented with 25 µg of kanamycin per ml. At an optical density at 600 nm of about 1, IPTG (isopropyl-ß-D-thiogalactopyranoside) was added to a final concentration of 100 µM to initiate enzyme induction. After another 18 h of growth, cells were harvested by centrifugation.
Strain characterization.
The phenotypic characterization of the bacterial strain was performed according to keys to identify Sinorhizobium sp. (17). Antibiotic resistance was determined by the disk plate method (12, 38). The 16S rRNA gene of strain S-30.7.5 was amplified from genomic DNA (33) as a 1.5-kb DNA fragment using the primers fD1 and rD1 (43). The sequence of the amplified 16S rRNA gene was aligned with published sequences obtained from the GenBank and EMBL databases by using the BLAST program (NCBI, http://www.ncbi.nlm.nih.gov).
DNA techniques, cloning, and His6 tag fusion.
Standard and recombinant DNA techniques were applied according to an established manual (33). Plasmids were prepared as described previously (8). Transformation of E. coli was performed with an electroporator Gene Pulser II (Bio-Rad Laboratories, Munich, Germany). DNA sequencing was performed on a LI-COR 4200 DNA sequencer (MWG Biotech, Ebersberg, Germany) using a Sequenase fluorescence-labeled primer cycle sequencing kit (Amersham Biosciences, Freiburg, Germany). DNA sequences were determined with the program DNASTAR (Lasergene, Madison, WI) and aligned with published sequences from the GenBank and EMBL databases by using the BLAST program (see above). The derived amino acid sequences were aligned by using the CLUSTAL W algorithm (40). All PCR DNA amplifications were performed in gradient thermocycler (Biometra, Göttingen, Germany) using the Proofstart PCR Kit (QIAGEN, Hilden, Germany). The afr gene was amplified from genomic DNA (1 µg) of S. morlense S-30.7.5 by using the primers 5'-ATGAA(CT)CGCTGGGGACTGATCGGCGCGAGCACGAT-3' and 5'-TCAAAGTCCCGTTTCGATCTCGAC-3' derived from DNA sequences flanking the SMc04400 locus of the sequenced S. meliloti 1021 genome (11). The PCR product was separated in a 1% (wt/vol) agarose gel from which it was purified by using a MinElute gel extraction kit (QIAGEN) and then cloned into the vector pCRII-TOPO to yield plasmid pPS18 containing the 1-kb afr gene. Plasmid pPS18 was used as a template for subcloning afr into the expression vector pET24a(+) (Novagen, Darmstadt, Germany) via the NdeI and BamHI restriction sites (underlined) of the primers 5'-TCTGCAGAATTCGCCCATATGAATCGCTGGGGACTGATC-3' and 5'-AGTGTGCTGGAATTCGGATCCTCAAAGTCCCGTTTCGAT-3' to yield plasmid pA6Ch1, which was transformed into E. coli BL21(DE3). To provide AFR with a C-terminal His6 tag, plasmid pPS18 and the primers 5'-TCTGCAGAATTCGCCCATATGAATCGCTGGGGACTGATC-3' and 5'-GGATCCTCA(GTG)6AAGTCCCGTTTCGATCTCGGC-3' were used to introduce the afr fusion into pET24a(+), yielding plasmid pA6Ch1HIS for transformation into E. coli BL21(DE3). All inserts of the expression plasmids were verified by DNA sequence analysis.
Anhydrofructose reductase purification.
For AFR purification each 1 g of wet cells of S. morelense S-30.7.5 was suspended in 3 ml of standard buffer (50 mM Bistris-HCl [pH 7.0]) containing DNase I (0.5 mg/ml) and then disrupted by sonification with a MSE Soniprep 150 (Curtin Matheson Scientific, Inc., Houston, TX). The cell debris was removed by centrifugation (5,000 x g for 15 min at 4°C), and the supernatant was filtered through a 0.2-µm-pore-size membrane filter. The filtrate was applied to a Q-Sepharose HP column (2 cm2 by 7 cm) equilibrated with the standard buffer, and AFR was eluted with a linear KCl gradient (0.07 to 1.5 M) in the same buffer. Fractions containing high AF-reductase activities (see assay below) were concentrated by ultrafiltration and then further purified on a Superdex 200 HR10 30 column (2 cm2 by 12 cm) equilibrated with the standard buffer. The eluted fractions with AFR were adsorbed to a Red Sepharose CL-6B affinity column (3 cm2 by 7 cm) and then eluted by 1.5 M KCl in the standard buffer. The eluate with AFR was concentrated by ultrafiltration, desalted on a Sephadex G25-SF column (2 cm2 by 10 cm) equilibrated with the standard buffer, and stored at 4°C and 20°C, respectively.
AFR-His6 was purified from E. coli BL21(DE3)/(pA6Ch1HIS). By using cells suspended in 50 mM potassium phosphate (pH 7.0), cell extracts were prepared as described above and then applied to a HiTrap Chelating Sepharose column (5 ml) equilibrated with 20 mM sodium phosphate (pH 7.4) containing 0.5 M NaCl. The column was washed with 5 volumes of equilibration buffer containing 0.05 M imidazole, followed by elution of AFR-His6 with 10 volumes of the same buffer containing 0.5 M imidazole. Eluted AFR was desalted and finally purified on a Q-Sepharose HP column as described above.
Enzyme assays.
AFR and monooxygenase activities were determined spectrophotometrically at 365 nm by recording the change in NADPH absorbance (
= 3.5 ml µmol1 cm1) at 30°C. The AFR assay contained in 1 ml of 100 µmol of Bistris-HCl (pH 6.5), 0.28 µmol of NADPH, 10 to 100 mU of AFR, and 30 to 100 µmol of substrate. The oxidation assay contained in 1 ml of 100 µmol of Tris-HCl (pH 9.0), 1.8 µmol of NADP+, 5 U of AFR, and 30 to 100 µmol of substrate. The reaction was started by substrate addition. The monooxygenase assay (18) contained in 1 ml of 100 µmol of Tris-HCl (pH 7.5) 0.28 µmol of NADPH, 0.1 µmol of FMN or FAD, and 100 µl of crude extract (1 to 3 mg of protein). The reaction was started by the addition of 20 µmol of AM. One unit of enzyme activity was defined as the amount of enzyme required to oxidize/reduce 1 µmol of NADPH/NADP+ min1 under standard assay conditions.
The pH optimum of AFR was determined using the following buffers (each 100 mM): sodium citrate and sodium acetate (pH 3.5-6.0), potassium phosphate and Bistris-HCl (pH 5.5 to 7.5), and Tris-HCl (pH 7.0 to 9.0). The effects of metal salts and EDTA were tested each at a concentration of 1 mM in the standard assay. The temperature stability of AFR was tested in 20 mM Bistris-HCl (pH 7.0) in the range 20 to 50°C, and the storage stability in the same buffer in the presence of 1 mM dithiothreitol or 0.5 mM NADP, respectively, at 20, 4, 25, and 30°C.
Analytical methods.
Protein concentration was determined with the bicinchoninic acid assay kit (Sigma-Aldrich, Munich, Germany). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (25) was carried out in 9% (wt/vol) slab gels (10 by 7 by 0.1 cm) using the protein standard (10 to 200 kDa) from MBI Fermentas (St. Leon-Roth, Germany). The gels were stained with Coomassie brilliant blue R-250.
The molecular mass of AF reductase was determined by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) with a Bruker Reflex III spectrometer (Bruker-Daltonics, Bremen, Germany) as described recently (5). The relative molecular mass of AFR was determined by gel filtration on Superdex 200 HR10 30 equilibrated with the standard buffer. Protein standards were from Serva (Heidelberg, Germany). The N-terminal amino acid sequence of AFR was determined with the Procise Protein Sequencing System (Applied Biosystems, Foster City, CA). Isoelectric focusing of AFR was performed on Servalyt Precotes gels (pH 3 to 5 and pH 3 to 10) according to the manufacturer's instruction manual (Serva, Heidelberg, Germany).
Sugars and keto sugars were analyzed by high-pressure liquid chromatography (HPLC) equipped with a refractive index detector. An Aminex HPX-87H H+ column (300 by 7.8 mm; Bio-Rad) was used with 0.5 mM H2SO4 as the mobile phase at 60°C and a flow rate of 0.5 ml/min. For comparisons, authentic sugars were used as references for all analytical analyses. Thin-layer chromatography (TLC) was performed with silica gel 60 plates (Merck, Darmstadt, Germany) using acetone-butanol-H2O (4:5:1) as the mobile phase and 2,4-dinitrophenylhydrazine-sulfuric acid reagent for staining.
1H nuclear magnetic resonance (NMR) spectra were recorded in D2O on an Avance 500 spectrometer (Bruker, Rheinstetten, Germany) at 500 MHz and 300K, using the standard pulse program provided by the manufacturer. The analytes were either lyophilized and then dissolved in D2O or directly analyzed in 10% (vol/vol) D2O.
Metabolic studies of 1,5-anhydro-D-fructose.
Late-log-phase cells grown as described above were harvested, washed, and resuspended in 20 mM Tris-HCl (pH 7.5) to give a suspension of approximately 100 mg of wet cells per ml. To 1 ml of the cell suspension, 40 µmol AF or AM, respectively, was added, followed by incubation at 28°C with shaking (142 rpm). Samples were analyzed by HPLC after removal of the cells by ultrafiltration.
Cell extracts of S. morelense S-30.7.5 late-log-phase cells were used to study the conversion of AM. The reaction mixture contained at 28°C in 1.4 ml of the following: 50 µmol of Tris-HCl (pH 7.5), cell extract (30 mg of protein), 20 µmol of AM, 4.2 µmol of NADPH, and 1.0 µmol of FMN. Samples were removed and analyzed by HPLC after deproteinization.
Bioconversions using anhydrofructose reductase.
Conversions with cosubstrate regeneration were run in 50-ml Erlenmeyer flasks with gentle stirring at 28°C. The reaction mixture contained in 10 ml (final volume) of 20 mM Bistris-HCl (pH 6.5) the following: a 60 mM concentration of substrate, 60 mM glucose 6-phosphate, 0.03 mM NADPH, 1.2 mM NADP+, 50 U of glucose 6-phosphate dehydrogenase (EC 1.1.1.49; Serva), and 50 U of AFR. When the reaction was complete, the products were recovered by ultrafiltration, followed by anion (Dowex AG 1x8, formiate, 200 to 400 mesh; Serva)- and cation (Dowex 50 WX8 H+, 200 to 400 mesh)-exchange chromatography.
GenBank accession numbers.
The anhydrofructose reductase gene (afr) and the Sinorhizobium morelense S-30.7.5 16S rRNA gene sequences were deposited in GenBank under accession numbers DQ140417 and DQ140416, respectively.
|
|
|---|
Characterization of the bacterial isolate S-30.7.5 as S. morelense.
The strain S-30.7.5 was characterized as an aerobic gram-negative rod with a polar flagellum capable of growing in complex (LB) and mineral medium with a wide range of carbohydrate substrates. Sequence analysis of 1,436 bp of the amplified 16S rRNA gene of strain S-30.7.5, and database alignments (40) over the total sequence length revealed the highest consensus to members of the genus Sinorhizobium (recently, a renaming of the genus to Ensifer was suggested [49]) and a global identity of 99% to the species S. morelense. Accordingly, phenotypic characterizations of strain S-30.7.5 also led to the genus Sinorhizobium species (17) and finally to the species S. morelense S-30.7.5, based on its multiple antibiotic resistance against kanamycin (1 mg ml1), erythromycin (600 µg ml1), chloramphenicol (250 µg ml1), penicillin G (50 µg ml1), and streptomycin (20 µg ml1), which is a distinctive feature of S. morelense (42).
Growth of S. morelense S-30.7.5 and catabolism of AF.
Fig. 1 illustrates the growth of S. morelense S-30.7.5 in a 2-liter bioreactor on a mineral medium containing 10 mM AF as a carbon source. After a lag period, the cells grew exponentially with a specific growth rate of µ = 0.17 h1 up to an absorbance (A600) of about 1.5. AFR was formed, along with growth reaching a high maximum activity of 5.8 U/mg of protein in the late exponential growth phase (Fig. 1). To determine how the cyclic ether AF was metabolized by S. morelense S-30.7.5, cell extracts were prepared and incubated with AF and equimolar amounts of NADPH. MS analysis showed that a cyclic polyol was formed but did not discriminate between the two enantiomeric forms AM or AG (data not shown). In contrast, HPLC and TLC afforded the identification of a single product with a retention time of 13.7 min and an Rf value of 0.45 that exactly matched those of authentic AM (Table 1). Furthermore, the AM formed from AF was found to be further metabolized in S. morelense S-30.7.5 to D-mannose (Fig. 2), a well-metabolizable substrate for bacterial cells. In accordance with this, specific monooxygenase activities in a range of 0.04 to 0.3 U/mg of protein capable of converting AM to D-mannose were detected in cell extracts of S. morelense S-30.7.5. Figure 2 shows two HPLC runs of samples removed from the reaction mixture containing the cell extract, AF, and NADPH after 10 and 25 min. The peak at 11.6 min, which had increased during prolonged incubation, corresponded to the retention time of authentic D-mannose. Since AF has a similar retention time as D-mannose the possibility existed that a fraction of AM was reoxidized to AF by the cell extract. However, an AM oxidizing activity was not detectable in the standard assay in the presence of NADP or NAD, which therefore excluded this possibility. When intact cells were incubated with AF the sugar was incorporated, and AM was found as the sole product in the supernatant, whereas D-mannose was not detectable, suggesting that D-mannose was phosphorylated upon its formation and therefore retained within the cells.
![]() View larger version (14K): [in a new window] |
FIG. 1. Growth of S. morelense S-30.7.5 on AF and formation of AFR. A culture of 50 ml grown on D-glucose was used to inoculate 1.5 liter of mineral medium containing 10 mM AF in a 2-liter bioreactor. The culture was grown at 28°C with aeration (4-liter air/min) and agitation (500 rpm). Growth (), AF concentration ( ), and specific AFR activity (U/mg of protein) in cell extracts ( ) were determined. All values represent means of double determinations.
|
|
View this table: [in a new window] |
TABLE 1. HPLC and TLC characteristics of various sugarsa
|
![]() View larger version (22K): [in a new window] |
FIG. 2. HPLC diagram of the conversion of AM to D-mannose by cell extracts of S. morelense S-30.7.5. For details, see Materials and Methods. The arrow indicates the elution peak of D-mannose at 11.6 min as the conversion product of AM at 14.1 min. 1, after 10 min of incubation; 2, after 25 min of incubation.
|
Purification and molecular properties of anhydrofructose reductase from S. morelense S-30.7.5.
AFR was purified from the cell extracts made from 3.5 g of wet biomass of S. morelense S-30.7.5. The purification procedure consisted of three chromatographic steps (Table 2) resulting in a homogeneous AFR preparation (Fig. 3A) with a specific activity of 489 U/mg of protein and a yield of 8%. AFR is a monomer since the relative molecular mass determined by SDS-PAGE (Mr of
40,000) was similar to that obtained by gel filtration (Mr of
38,200). A precise molecular mass of 35,100 ± 130 Da was determined by MALDI-TOF-MS, which is in agreement with value derived from the AFR gene (see below). AFR has a pI of pH 4.3 as determined by isoelectric focusing. When AFR was stored at 20 or at 0°C the enzyme lost 50% of its initial activity within 50 days.
|
View this table: [in a new window] |
TABLE 2. Purification of the native AFR from S. morelense S-30.7.5 and the His6-tagged AFR variant from E. coli BL21(DE3)/(pA6Ch1)
|
![]() View larger version (67K): [in a new window] |
FIG. 3. SDS-PAGE of AFR preparations. (A) AFR isolated from S. morelense S-30.7.5. Lanes: 1, protein standards; 2, cell extract (50 µg of protein), AFR indicated by arrow; 3, final preparation after Red Sepharose (5 µg of protein) on separate gel. (B) Recombinant His6-tagged AFR from E. coli. Lanes: 1, protein standards; 2, cell extract (50 µg of protein), AFR indicated by arrow; 3, final preparation after Q-Sepharose (15 µg of protein) on separate gel.
|
|
View this table: [in a new window] |
TABLE 3. Substrates and products of AFR from S. morelense S-30.7.5
|
![]() View larger version (26K): [in a new window] |
FIG. 4. 1H-NMR spectra of authentic standards of AF, 1,5-anhydro-D-glucitol, and AM and of the product (bottom) of an AF bioconversion with AFR from S. morelense S-30.7.5.
|
|
View larger version (7K): [in a new window] |
FIG. 5. Reaction equation of AFR showing the stereoselective conversion of AF to AM.
|
Anhydrofructose reductase primary structure analysis and assignment to the GFO/IDH/MocA protein family.
Using the afr-derived amino acid sequence for a BLASTP search in the NCBI database, we found no oxidoreductase with known function, but we retrieved a group of putative oxidoreductases with high sequence identities (73 to 86%) to AFR assigned to the bacteria S. meliloti, Mesorhizobium loti, Brucella suis, and B. melitensis (see legend to Fig. 6). Also, another prominent group of proteins, but with low sequence identities to AFR (<30%), was retrieved that belonged to the GFO/IDH/MocA family with glucose-fructose oxidoreductase (GFOR) from Zymomonas mobilis as a representative member (52). The sequence alignments (Fig. 6) showed that AFR shares highly conserved sequence motifs with GFOR and related members of the group. These include the characteristic NADP binding motif (-G5XXGXSXXA13-), the conserved substrate-binding motif (-A86GKHVLCEK94-), and the catalytic triad comprising two invariant residues (Lys94 and Asp176) and His180, which is Tyr217 in GFOR (21, 45). Based on these distinctive features that AFR has in common with the GFO/IDH/MocA proteins and in particular with GFOR of Z. mobilis, we assigned AFR of S. morelense S-30.7.5 as a new member of this family, and confirmed it by three-dimensional structure analysis of the AFR and site-directed mutagenesis (T. Dambe, A. Kühn, F. Giffhorn, and A. Scheidig, submitted for publication).
![]() View larger version (95K): [in a new window] |
FIG. 6. Multiple sequence alignment of the deduced amino acid sequences of anhydrofructose reductase (AFR) from S. morelense S-30.7.5 with GFO/IDH/MocA oxidoreductases, xylose dehydrogenase of H. marismortui, and putative oxidoreductases from S. meliloti 1021, M. loti, B. suis, and B. melitensis. The alignment was generated by means of CLUSTAL W with the Blosum62 matrix (40). NCBI/GenBank accession numbers: S. morelense S-30.7.5 AFR (DQ140417); E. meliloti 1021 Smc04400 (NP_387411); M. loti Mlr3046 (NP_104243); Z. mobilis GFOR (CAB_02496); H. marismortui XylDH (YP_137464); E. meliloti MocA, scyllo-inosamin/myoinositol 2-dehydrogenase (CAA55269); L. plantarum IDH, myo-inositol 2-dehydrogenase (NP_786809); B. suis oxidoreductase (NP_699023); B. melitensis oxidoreductase AG3254 (NP_538938). Identical residues among the polypeptides are underlined in black; variable residues are shaded. Framed boxes indicate the highly conserved motifs of cosubstrate and substrate binding. Arrows highlight catalytic residues (see the text).
|
![]() View larger version (16K): [in a new window] |
FIG. 7. Bioconversion of AF to AM with cosubstrate regeneration. The conversion was performed in a final volume 10 ml of 20 mM Bistris (pH 6.5) at 28°C. The reaction mixture contained 60 mM AF, 60 mM glucose-6-phosphate, 1.2 mM NADP, 0.03 mM NADPH, 50 U of AFR-His6, and 50 U of glucose-6-phosphate dehydrogenase. AF and AM concentrations were determined by HPLC. The values given represent means of double determinations.
|
E) were directly proportional to the amounts of AF added to the assay. Conversely, the concentrations of AF could be calculated on the basis of
E and the extinction coefficient for NADPH at 340 nm. In the given assay, 5 nmol of AF could be determined with sufficient accuracy. |
|
|---|
![]() View larger version (20K): [in a new window] |
FIG. 8. Pathway of the AF catabolism in S. morelense S-30.7.5. AFR, anhydrofructose reductase; CYP, cytochrome P450; CYPR, CYP reductase; ED-pathway, Entner-Doudoroff pathway.
|
Interestingly, in S. meliloti 1021 the afr gene (locus SMc04400) is localized on the 3.65-Mb chromosome, which contains the majority of genes coding for core metabolic functions (17). This finding may suggest a superior metabolic role of AFR, in particular since the corresponding genes were also found in the intracellular pathogens Brucella suis and B. melitensis, which have striking metabolic similarities with plant symbionts such as S. meliloti and M. loti (14, 30). Unfortunately, analysis of the gene region adjacent to SMc04400 provided no further information on its true function. The ORF flanking upstream of SMc04400 codes for a putative transcription regulator of the LacI-type, whereas the ORFs downstream code for putative enzymes of fatty acid synthesis and an L-sorbosone dehydrogenase.
Application of anhydrofructose reductase.
Due to structural similarities between AF and the osones listed in Table 3, these compounds were accepted as substrates by AFR. One requirement seems to be the pyran ring structure with the C-2 carbonyl group, as in AF (16, 23). The best structural match to AF (1-deoxy-D-glucosone) is obviously D-glucosone, which explains the high stereoselectivity of its conversion to D-mannose by AFR. Since D-mannose is still manufactured from birch and beech wood hydrolysates, we highlight a biocatalytic route of how it can be conveniently prepared from low-cost D-glucose (Fig. 9). The chemical synthesis of AM and D-mannose from AF and D-glucosone by catalytic hydrogenation is also possible (3, 16) but less effective than the synthesis with AFR. Although D-mannose is a well-established sugar on the market, uses for AM are just emerging, e.g., as a chiral building block in antivirals (41) and as a potential agent for the treatment of type II diabetes (2).
|
View larger version (9K): [in a new window] |
FIG. 9. Principle of the biocatalytic synthesis of D-mannose from D-glucose. D-glucose 1 is oxidized by pyranose 2-oxidase (P2Ox) to D-glucosone 2 (5), which can be reduced to D-mannose 3 by anhydrofructose reductase (AFR).
|
This study was financially supported by the European Union within the 5th Framework Programme NEPSA under contract no. QLK3-CT-2001-02400.
|
|
|---|
-D-glucans to 1,5-D-anhydrofructose. Phytochemistry 27:3401-3403.[CrossRef]
-D-glucans to echinosporin (5-Epipentenomycin I). Phytochemistry 5:1419-1423.[CrossRef]
-1,4-glucan lyase. Biochemistry 42:13081-13090.[CrossRef][Medline]
Asp) alters NADP-containing glucose-fructose oxidoreductase of Zymomonas mobilis into a glucose dehydrogenase with dual coenzyme specificity. J. Biol. Chem. 272:13126-13133.
-glucopyranosyl-D-fructose). Carbohydr. Res. 338:2221-2225.[CrossRef][Medline]
-1,4-Glucan lyases producing 1,5-anhydro-D-fructose from starch and glycogen have sequence similarity to
-glucosidases. Biochim. Biophys. Acta 1433:1-15.[CrossRef][Medline]
-1,4-glucan lyase in the fungus Anthracobia melaloma. Biochim. Biophys. Acta 1672:120-129.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»